What is the official website of Autolus Therapeutics ?

The official website of Autolus Therapeutics is http://www.autolus.com.

What is Autolus Therapeutics's cybersecurity risk score?

Autolus Therapeutics has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Autolus Therapeutics experienced?

According to Rankiteo, Autolus Therapeutics currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Autolus Therapeutics been affected by any supply chain cyber incidents ?

According to Rankiteo, Autolus Therapeutics has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Autolus Therapeutics have SOC 2 Type 1 certification ?

According to Rankiteo, Autolus Therapeutics is not certified under SOC 2 Type 1.

Does Autolus Therapeutics have SOC 2 Type 2 certification ?

According to Rankiteo, Autolus Therapeutics does not hold a SOC 2 Type 2 certification.

Does Autolus Therapeutics comply with GDPR ?

According to Rankiteo, Autolus Therapeutics is not listed as GDPR compliant.

Does Autolus Therapeutics have PCI DSS certification ?

According to Rankiteo, Autolus Therapeutics does not currently maintain PCI DSS compliance.

Does Autolus Therapeutics comply with HIPAA ?

According to Rankiteo, Autolus Therapeutics is not compliant with HIPAA regulations.

Does Autolus Therapeutics have ISO 27001 certification ?

According to Rankiteo,Autolus Therapeutics is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Autolus Therapeutics operate in ?

Autolus Therapeutics operates primarily in the Biotechnology industry.

How many employees does Autolus Therapeutics have ?

Autolus Therapeutics employs approximately 674 people worldwide.

Does Autolus Therapeutics own any subsidiaries ?

Autolus Therapeutics presently has no subsidiaries across any sectors.

How many LinkedIn followers does Autolus Therapeutics have ?

Autolus Therapeutics's official LinkedIn profile has approximately 28,568 followers.

Does Autolus Therapeutics have a Crunchbase profile ?

Yes, Autolus Therapeutics has an official profile on Crunchbase, which can be accessed here: https://www.crunchbase.com/organization/autolus.

Does Autolus Therapeutics have a LinkedIn profile ?

Yes, Autolus Therapeutics maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/autolus-ltd-.

How many cybersecurity incidents has Autolus Therapeutics experienced ?

As of September 4, 2026, Rankiteo reports that Autolus Therapeutics has not experienced any cybersecurity incidents.

How many peer or competitor companies does Autolus Therapeutics have ?

Autolus Therapeutics has an estimated 1,078 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Autolus Therapeutics

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

Autolus Therapeutics Vendor Cyber Rating & Cyber Score

autolus.com

cb in

Add Your Compliance Badge

Autolus is a CAR T cell therapy company. We are applying our extensive programming capabilities to develop advanced autologous T cell therapies that have the potential to deliver life-changing therapies to patients with cancer and autoimmune diseases.

Autolus Therapeutics A.I CyberSecurity Scoring

Scoring History

Autolus Therapeutics

Autolus Therapeutics CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Autolus Therapeutics Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Autolus Therapeutics

Incidents vs Biotechnology Industry Avg (This Year)

No incidents recorded for Autolus Therapeutics in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Autolus Therapeutics in 2026.

Incident Types Autolus Therapeutics vs Biotechnology Industry Avg (This Year)

No incidents recorded for Autolus Therapeutics in 2026.

Incident History - Autolus Therapeutics (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Autolus Therapeutics Subsidiaries

Parent Company

Autolus Therapeutics

Biotechnology

Website: http://www.autolus.com

Company Size: 674

No subsidiary data available for this company.

Loading…

Autolus Therapeutics Similar Companies

Regeneron

cb regeneron.com

At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in. Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media. An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.

Loading…

NEWS

Autolus Therapeutics CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

December 27, 2025 08:00 AM

Is Autolus Therapeutics plc (AUTL) The Best Get Rich Fast Stocks to Buy Right Now?

Autolus Therapeutics plc (NASDAQ:AUTL) is among the Best Get Rich Fast Stocks to Buy Right Now. As of December 24, Autolus Therapeutics plc...

Read Article

December 01, 2025 08:00 AM

Autolus Therapeutics (Nasdaq: AUTL) adds ex-BioNTech strategy chief Ryan Richardson to its Board of Directors

Autolus Therapeutics appoints Ryan Richardson, BioNTech's former chief strategy officer, to its board as the company advances its first...

Read Article

November 15, 2025 08:00 AM

Autolus Therapeutics plc (NASDAQ:AUTL) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year

It's been a good week for Autolus Therapeutics plc ( NASDAQ:AUTL ) shareholders, because the company has just released...

Read Article

November 13, 2025 08:00 AM

How Investors Are Reacting To Autolus Therapeutics (AUTL) Trimming Losses and Appointing a New Finance Chief

Autolus Therapeutics recently reported third quarter 2025 earnings, showing a net loss of US$79.12 million, a slight improvement from the...

Read Article

October 30, 2025 07:00 AM

Why is Autolus Therapeutics plc (AUTL) One of the Best Stocks Under $5 With Highest Upside Potential?

Autolus Therapeutics plc (NASDAQ:AUTL) is one of the best stocks under $5 with highest upside potential. Autolus Therapeutics plc...

Read Article

August 13, 2025 07:00 AM

Autolus Therapeutics sees cash runway to launch, commercialization of obe-cel

Cash, cash equivalents and marketable securities at June 30, 2025, totalled $454.3 million, as compared to $588.0 million at December 31,...

Read Article

May 20, 2025 07:00 AM

Autolus Therapeutics plc (AUTL): Analysts See 697% Upside Potential

We recently published an article titled 13 Best Multibagger Stocks to Invest in Now. Autolus Therapeutics plc (NASDAQ:AUTL) was one of the...

Read Article

March 06, 2025 08:00 AM

Is Autolus Therapeutics plc (AUTL) the Best UK Growth Stock to Buy Now?

In this article, we are going to take a look at where Autolus Therapeutics plc (NASDAQ:AUTL) stands against the other UK growth stocks.

Read Article

June 19, 2024 07:00 AM

Autolus Therapeutics’ CAR-T Cell Manufacturing Facility, Stevenage, UK

Autolus Therapeutics is building a facility, The Nucleus, in Stevenage, UK, for the manufacture of CAR) T-cell therapies for cancer.

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-85456

SUMMARY

MOOS-IvP through 24.8.1 fails to properly validate variable names extracted from alog files in the SplitHandler, allowing attackers to write files outside the split directory. Attackers can supply crafted alog files with backslash sequences in variable names to escape the output directory and append to arbitrary files on Windows systems.

Published

Date2026-09-03

Updated

Date2026-09-03

RISK INFORMATION (Score: 5.5)

cvss3

Base Score: 5.5

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N

cvss4

Base Score: 6.8

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

1.8

REFERENCES

CVE-2026-85455

SUMMARY

MOOS core-moos through 10.4.0 contains a buffer over-read vulnerability in CMOOSCommPkt where a four-byte packet triggers out-of-bounds memory access during deserialization. Attackers can open a TCP connection to the MOOSDB port and send a crafted short packet to read memory before authentication.

Published

Date2026-09-03

Updated

Date2026-09-03

RISK INFORMATION (Score: 8.2)

cvss3

Base Score: 8.2

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:H

cvss4

Base Score: 8.8

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

4.2

Exploitability

3.9

REFERENCES

CVE-2026-85454

SUMMARY

MOOS core-moos through 10.4.0 contains a buffer overflow vulnerability in CMOOSSerialPort::GetTelegram() that writes a NUL terminator one byte past the serial telegram stack buffer. Attackers controlling the serial line can send a full-length telegram to trigger the off-by-one write, corrupting the stack and potentially enabling code execution.

Published

Date2026-09-03

Updated

Date2026-09-03

RISK INFORMATION (Score: 6.1)

cvss3

Base Score: 6.1

Complexity: LOW

CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:H

cvss4

Base Score: 5.2

Complexity: LOW

CVSS:4.0/AV:P/AC:L/AT:N/PR:N/UI:N/VC:N/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.2

Exploitability

0.9

REFERENCES

CVE-2026-85453

SUMMARY

MOOS core-moos through 10.4.0 fails to escape database contents when rendering MOOSDB HTTP pages, allowing attackers to inject malicious scripts. Any MOOS publisher can set variable values containing script payloads that execute in the browser of operators viewing the web interface.

Published

Date2026-09-03

Updated

Date2026-09-03

RISK INFORMATION (Score: 6.1)

cvss3

Base Score: 6.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.7

Exploitability

2.8

REFERENCES

CVE-2026-85452

SUMMARY

MOOS ui-moos through 50b9c6c contains a buffer overflow vulnerability in ScopeTabPane.cpp and ScopeGrid.cpp where client and variable names are formatted into fixed 1024-byte buffers using sprintf without length validation. Attackers can supply arbitrarily long MOOS identifiers that overflow the buffers when an operator selects process list entries or pokes variables, enabling code execution.

Published

Date2026-09-03

Updated

Date2026-09-03

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

cvss4

Base Score: 8.7

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

5.9

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…